MA52087A - Nouveaux vecteurs de virus adéno-associés (aav), vecteurs aav ayant une déamidation de capside réduite et leurs utilisations - Google Patents
Nouveaux vecteurs de virus adéno-associés (aav), vecteurs aav ayant une déamidation de capside réduite et leurs utilisationsInfo
- Publication number
- MA52087A MA52087A MA052087A MA52087A MA52087A MA 52087 A MA52087 A MA 52087A MA 052087 A MA052087 A MA 052087A MA 52087 A MA52087 A MA 52087A MA 52087 A MA52087 A MA 52087A
- Authority
- MA
- Morocco
- Prior art keywords
- aav
- vectors
- capside
- deamidation
- adeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862635964P | 2018-02-27 | 2018-02-27 | |
US201862635968P | 2018-02-27 | 2018-02-27 | |
US201862663788P | 2018-04-27 | 2018-04-27 | |
US201862663797P | 2018-04-27 | 2018-04-27 | |
US201862667587P | 2018-05-06 | 2018-05-06 | |
US201862667881P | 2018-05-07 | 2018-05-07 | |
US201862667888P | 2018-05-07 | 2018-05-07 | |
US201862677471P | 2018-05-29 | 2018-05-29 | |
US201862677474P | 2018-05-29 | 2018-05-29 | |
US201862667585P | 2018-05-29 | 2018-05-29 | |
US201862703670P | 2018-07-26 | 2018-07-26 | |
US201862703673P | 2018-07-26 | 2018-07-26 | |
US201862722382P | 2018-08-24 | 2018-08-24 | |
US201862722388P | 2018-08-24 | 2018-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52087A true MA52087A (fr) | 2021-06-02 |
Family
ID=67809202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052087A MA52087A (fr) | 2018-02-27 | 2019-02-27 | Nouveaux vecteurs de virus adéno-associés (aav), vecteurs aav ayant une déamidation de capside réduite et leurs utilisations |
Country Status (14)
Country | Link |
---|---|
US (1) | US20210123073A1 (fr) |
EP (1) | EP3768695A4 (fr) |
JP (1) | JP2021515548A (fr) |
KR (1) | KR20210006327A (fr) |
CN (1) | CN112236443A (fr) |
AU (1) | AU2019228504A1 (fr) |
BR (1) | BR112020017278A2 (fr) |
CA (1) | CA3091795A1 (fr) |
CL (1) | CL2020002201A1 (fr) |
IL (1) | IL276860A (fr) |
MA (1) | MA52087A (fr) |
MX (1) | MX2020008932A (fr) |
SG (1) | SG11202007942YA (fr) |
WO (1) | WO2019169004A1 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL257628B2 (en) | 2015-09-28 | 2023-04-01 | Univ North Carolina Chapel Hill | Methods and compositions for stealth virus antibody vectors |
SG11202009452WA (en) | 2018-04-03 | 2020-10-29 | Stridebio Inc | Antibody-evading virus vectors |
EP3884057A4 (fr) * | 2018-12-21 | 2022-09-07 | The University of North Carolina at Chapel Hill | Gènes galc optimisés et cassettes d'expression et leur utilisation |
AR118465A1 (es) | 2019-03-21 | 2021-10-06 | Stridebio Inc | Vectores de virus adenoasociados recombinantes |
IL292297A (en) | 2019-10-17 | 2022-06-01 | Stridebio Inc | Adeno-associated viral vectors for the treatment of Niemann-Pick type c disease |
EP4048681A4 (fr) * | 2019-10-21 | 2024-03-20 | Univ Pennsylvania | Variants d'aav3b présentant un rendement de production et un tropisme hépatique améliorés |
US20230204595A1 (en) * | 2020-01-03 | 2023-06-29 | Sarepta Therapeutics, Inc. | Methods for analyzing aav capsid proteins |
WO2021183433A1 (fr) * | 2020-03-09 | 2021-09-16 | University Of Massachusetts | Thérapie de remplacement de gène pour le syndrome de foxg1 |
CA3183153A1 (fr) | 2020-06-17 | 2021-12-23 | Christian HINDERER | Compositions et methodes pour le traitement de patients de therapie genique |
IL299762A (en) | 2020-07-13 | 2023-03-01 | Univ Pennsylvania | Useful preparations for the treatment of Charcot-Marietot disease |
TW202229315A (zh) * | 2020-10-18 | 2022-08-01 | 賓州大學委員會 | 改良的腺相關病毒(aav)載體及其用途 |
CA3209779A1 (fr) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Therapie genique de ceroides-lipofuscinoses neuronales |
EP4323520A1 (fr) | 2021-04-12 | 2024-02-21 | The Trustees of The University of Pennsylvania | Compositions utiles pour le traitement de l'amyotrophie spinale et bulbaire (sbma) |
WO2023081807A1 (fr) * | 2021-11-04 | 2023-05-11 | The Trustees of the University of Pennsylvania Penn Center for Innovation | Compositions et procédés pour réduire les taux de pcsk9 chez un sujet |
WO2023133584A1 (fr) | 2022-01-10 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Compositions utiles dans le traitement d'une leucodystrophie métachromatique |
AR128239A1 (es) | 2022-01-10 | 2024-04-10 | Univ Pennsylvania | Composiciones y métodos útiles para el tratamiento de trastornos mediados por c9orf72 |
WO2023196892A1 (fr) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Immunisation passive avec des anticorps neutralisants anti-aav pour empêcher la transduction hors cible de vecteurs aav administrés par voie intrathécale |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070172460A1 (en) * | 2003-03-19 | 2007-07-26 | Jurgen Kleinschmidt | Random peptide library displayed on aav vectors |
ES2411479T3 (es) * | 2003-09-30 | 2013-07-05 | The Trustees Of The University Of Pennsylvania | Clados de virus adeno-asociados (AAV), secuencias, vectores que los contienen, y usos de los mismos |
EP3085389A1 (fr) * | 2005-04-07 | 2016-10-26 | The Trustees Of The University Of Pennsylvania | Procédé d'augmentation de la fonction d'un vecteur aav |
BR112017005892A2 (pt) * | 2014-09-24 | 2017-12-12 | Hope City | variantes de vetor de vírus adeno-associado para edição de genoma de alta eficácia e métodos da mesma |
EP3224362A4 (fr) * | 2014-11-26 | 2018-06-06 | The Regents of The University of California | Compositions thérapeutiques comprenant des facteurs de transcription et leurs procédés de préparation et d'utilisation |
SG11201808812RA (en) * | 2016-04-15 | 2018-11-29 | Univ Pennsylvania | Novel aav8 mutant capsids and compositions containing same |
CN109715650B (zh) * | 2016-07-26 | 2024-03-08 | 生物马林药物股份有限公司 | 新颖腺相关病毒衣壳蛋白 |
BR112019002934A2 (pt) * | 2016-08-15 | 2019-05-14 | Genzyme Corporation | métodos para detecção de aav |
JOP20190200A1 (ar) * | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | تركيبات نافعة في معالجة ضمور العضل النخاعي |
SG10201912976WA (en) * | 2017-02-28 | 2020-02-27 | Univ Pennsylvania | Adeno-associated virus (aav) clade f vector and uses therefor |
-
2019
- 2019-02-27 BR BR112020017278-2A patent/BR112020017278A2/pt unknown
- 2019-02-27 US US16/975,545 patent/US20210123073A1/en active Pending
- 2019-02-27 CN CN201980029022.1A patent/CN112236443A/zh active Pending
- 2019-02-27 MA MA052087A patent/MA52087A/fr unknown
- 2019-02-27 WO PCT/US2019/019861 patent/WO2019169004A1/fr unknown
- 2019-02-27 AU AU2019228504A patent/AU2019228504A1/en active Pending
- 2019-02-27 JP JP2020545159A patent/JP2021515548A/ja active Pending
- 2019-02-27 CA CA3091795A patent/CA3091795A1/fr active Pending
- 2019-02-27 EP EP19760152.9A patent/EP3768695A4/fr active Pending
- 2019-02-27 MX MX2020008932A patent/MX2020008932A/es unknown
- 2019-02-27 SG SG11202007942YA patent/SG11202007942YA/en unknown
- 2019-02-27 KR KR1020207027462A patent/KR20210006327A/ko active Search and Examination
-
2020
- 2020-08-23 IL IL276860A patent/IL276860A/en unknown
- 2020-08-26 CL CL2020002201A patent/CL2020002201A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL276860A (en) | 2020-10-29 |
US20210123073A1 (en) | 2021-04-29 |
CL2020002201A1 (es) | 2020-12-18 |
AU2019228504A1 (en) | 2020-09-10 |
EP3768695A4 (fr) | 2022-04-06 |
MX2020008932A (es) | 2020-10-01 |
WO2019169004A9 (fr) | 2019-10-31 |
JP2021515548A (ja) | 2021-06-24 |
WO2019169004A1 (fr) | 2019-09-06 |
SG11202007942YA (en) | 2020-09-29 |
BR112020017278A2 (pt) | 2020-12-22 |
EP3768695A1 (fr) | 2021-01-27 |
WO2019169004A8 (fr) | 2019-12-05 |
CN112236443A (zh) | 2021-01-15 |
CA3091795A1 (fr) | 2019-09-06 |
KR20210006327A (ko) | 2021-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52087A (fr) | Nouveaux vecteurs de virus adéno-associés (aav), vecteurs aav ayant une déamidation de capside réduite et leurs utilisations | |
IL276859A (en) | Novel adeno-associated virus (AAV) vectors, AAV vectors with reduced capsid deamidation and uses thereof | |
BR112018071182A2 (pt) | entrega do vetor de vírus adenoassociado de micro-distrofina para tratar distrofia muscular | |
DK3596222T3 (da) | Adenoassocieret virusvektorfremføring af muskelspecifik mikro-dystrophin til behandling af muskeldystrofi | |
DK3684423T3 (da) | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf | |
PH12020500466A1 (en) | Lipid nanoparticle formulations of non-viral, capsid-free dna vectors | |
DK3445773T3 (da) | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf | |
CL2019000392A1 (es) | Métodos para detectar aav. | |
DK3589730T3 (da) | Klade f adeno-associeret virus (aav) vektor og anvendelse deraf | |
MA42934A (fr) | Vecteurs de facteur viii à virus adéno-associé, particules virales associées et formulations thérapeutiques comprenant ceux-ci | |
EA202091004A1 (ru) | Аденовирус и пути его применения | |
MA44681A (fr) | Administration de b-sarcoglycane et de microarn-29 à l'aide d'un vecteur de virus adéno-associé, et traitement de la dystrophie musculaire | |
EA202091074A1 (ru) | Аденовирус и его применения | |
DK3390430T3 (da) | Human immundefektvirus-antigener, vektorer, sammensætninger og fremgangsmåder til anvendelse deraf | |
EA201791460A1 (ru) | N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения | |
EA201792500A1 (ru) | Aav-опосредованная экспрессия антител против гриппа и способы их использования | |
PE20150163A1 (es) | Composicion y metodos para una transferencia de genes altamente eficiente usando variantes capside aav | |
IL286464A (en) | A virus of vectors related to recombinant DNA | |
MA49298A (fr) | Virus de la maladie de newcastle et leurs utilisations | |
EA202091104A1 (ru) | Аденовирус и пути его применения | |
DK3294756T3 (da) | Retroviral partikel, omfattende mindst to forskellige indkapslede, ikke-virale RNA'er | |
SG11201704919SA (en) | Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) | |
IL299380A (en) | An improved adenovirus as a vector for gene therapy | |
DK4017871T3 (da) | Adenoassocieret virusvektoradministration af alfa-sarcoglycan og behandling af muskeldystrofi | |
EA202192101A1 (ru) | Соединения и их применение |